SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-152195
Filing Date
2021-12-21
Accepted
2021-12-21 16:24:57
Documents
1
Period of Report
2021-12-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2135922-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2135922-5_4seq1.xml 4 3274
  Complete submission text file 0001104659-21-152195.txt   4674
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Issuer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARRAY BIOPHARMA INC. 3200 WALNUT ST. BOULDER CO 80301
Business Address
Oltmans Curtis Gale (Reporting) CIK: 0001714982 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38114 | Film No.: 211509689